Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-12-02Clinical Trial Update: Vitamin D Treatment in Ulcerative Colitis [NA]
A clinical trial investigating vitamin D treatment for ulcerative colitis has been withdrawn from the registry.
-
CLINICAL_TRIALS withdrawal · 2014-11-20Clinical Trial Update: Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease [Phase 2]
A Phase 2 trial of low-dose naltrexone for inflammatory bowel disease has been withdrawn. The conditions involved include Crohn's disease an…
-
CLINICAL_TRIALS withdrawal · 2013-12-13Clinical Trial Update: Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis. [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing retard phosphatidylcholine versus mesalazine for achieving remission in ulcerative colitis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-02Clinical Trial Update: Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis [Phase 1]
Withdrawn Phase 1 clinical trial evaluating pharmacodynamics and safety of HGS1025 in patients with Ulcerative Colitis.
-
CLINICAL_TRIALS withdrawal · 2013-06-24Clinical Trial Update: A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis [Phase 2]
A Phase 2 trial evaluating GSK1605786 for active ulcerative colitis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-04-23Clinical Trial Update: Cerebral Resonance Magnetic Imaging During Rectal Distention
The trial NCT00213330 sponsored by University Hospital Rouen has been withdrawn. It studied cerebral resonance magnetic imaging during recta…
-
CLINICAL_TRIALS withdrawal · 2009-06-25Clinical Trial Update: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis [Phase 3]
A Phase 3 trial evaluating visilizumab for intravenous steroid-refractory ulcerative colitis was withdrawn.